SPDR S&P Biotech ETF
199 hedge funds and large institutions have $3.15B invested in SPDR S&P Biotech ETF in 2015 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 51 increasing their positions, 71 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
22.59% less ownership
Funds ownership: 159.26% → 136.68% (-23%)
28% less repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 71
59% less call options, than puts
Call options by funds: $490M | Put options by funds: $1.2B
Holders
199
Holding in Top 10
6
Calls
$490M
Puts
$1.2B
Top Buyers
| 1 | +$60.2M | |
| 2 | +$44.2M | |
| 3 | +$16.9M | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$15M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$12M |
Top Sellers
| 1 | -$403M | |
| 2 | -$49.7M | |
| 3 | -$39.2M | |
| 4 |
SG Americas Securities
New York
|
-$35.2M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$29.3M |